Holdings of Vivo Capital, LLC
41 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 64.4 % of the equity sleeve
Sector breakdown
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 92.3 %
- FR 7.6 %
- GB 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 38 | 1B $ | 92.35 % |
| 2 | FR | 2 | 82.4M $ | 7.55 % |
| 3 | GB | 1 | 1.1M $ | 0.10 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Erasca Inc | 12,151,480 | 196.6M $ | |
| 2 | Praxis Precision Medicines Inc | 338,895 | 109.2M $ | |
| 3 | Terns Pharmaceuticals Inc | 1,334,418 | 70.4M $ | |
| 4 | Trevi Therapeutics Inc | 5,094,668 | 60.8M $ | |
| 5 | DBV Technologies SA | 2,667,569 | 55.7M $ | |
| 6 | Compass Therapeutics Inc | 9,545,466 | 50.5M $ | |
| 7 | Tango Therapeutics Inc | 2,154,780 | 45.1M $ | |
| 8 | SAB Biotherapeutics Inc | 11,420,000 | 43.7M $ | |
| 9 | Corvus Pharmaceuticals Inc | 2,805,816 | 41M $ | |
| 10 | Dianthus Therapeutics Inc | 353,998 | 29.7M $ | |
| 11 | Dyne Therapeutics Inc | 1,557,466 | 28.2M $ | |
| 12 | Abivax SA | 239,539 | 26.7M $ | |
| 13 | Minerva Neurosciences Inc | 4,322,747 | 26M $ | |
| 14 | Aclaris Therapeutics Inc | 6,666,666 | 25M $ | |
| 15 | ORIC Pharmaceuticals Inc | 1,848,786 | 23.4M $ | |
| 16 | Alto Neuroscience Inc | 1,035,551 | 23.3M $ | |
| 17 | SENSEI BIOTHERAPEUTICS INC | 722,020 | 22.8M $ | |
| 18 | ArriVent Biopharma Inc | 885,916 | 20.4M $ | |
| 19 | LB Pharmaceuticals Inc | 800,000 | 19.7M $ | |
| 20 | VeraDermics Inc | 300,000 | 18.9M $ | |
| 21 | CAMP4 THERAPEUTICS CORP | 4,246,568 | 18.7M $ | |
| 22 | Design Therapeutics Inc | 1,612,903 | 17.2M $ | |
| 23 | Cogent Biosciences Inc | 422,300 | 16.3M $ | |
| 24 | Geron Corp | 8,671,797 | 12.9M $ | |
| 25 | Unicycive Therapeutics Inc | 1,789,916 | 11.8M $ | |
| 26 | AN2 Therapeutics Inc | 3,153,640 | 10.8M $ | |
| 27 | Olema Pharmaceuticals Inc | 671,843 | 10M $ | |
| 28 | Soleno Therapeutics Inc | 294,909 | 9.9M $ | |
| 29 | OnKure Therapeutics Inc | 1,927,710 | 8M $ | |
| 30 | Surrozen Inc | 260,000 | 7.6M $ | |
| 31 | ALX Oncology Holdings Inc | 3,184,713 | 6.4M $ | |
| 32 | Monopar Therapeutics Inc | 90,500 | 5M $ | |
| 33 | PepGen Inc | 2,325,000 | 4.1M $ | |
| 34 | Sera Prognostics Inc | 1,650,440 | 3.4M $ | |
| 35 | Tenax Therapeutics Inc | 208,333 | 3.3M $ | |
| 36 | Viridian Therapeutics Inc | 166,288 | 3.3M $ | |
| 37 | Instil Bio Inc | 292,743 | 2.4M $ | |
| 38 | PASITHEA THERAPEUTICS CORP | 2,100,000 | 1.6M $ | |
| 39 | Compass Pathways plc | 200,000 | 1.1M $ | |
| 40 | BOLT BIOTHERAPEUTICS INC | 72,414 | 292.6K $ | |
| 41 | Precision BioSciences Inc | 4,675 | 25.7K $ | |